Syapse is excited and encouraged by the passage of the 21st Century Cures Act. The continued funding of the Cancer Moonshot and Precision Medicine Initiative illustrates our government's commitment to fight cancer and support medical innovation. Most importantly, it ensures timely access to lifesaving therapies by encouraging the use of real-world evidence for drug approvals. The Cures Act leaves us optimistic about the future of medicine in America, where patients are treated with precise, individualized care. Syapse is dedicated to the goals embodied in the Cures Act through developing and delivering software to improve care, reduce costs and improve the patient experience through precision medicine.